Structure and signalling in the IL-17 receptor family
Open accessThe DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Abstract
Interleukin-17A (IL-17A), the hallmark cytokine of the newly defined T helper 17 (T(H)17) cell subset, has important roles in protecting the host against extracellular pathogens, but also promotes inflammatory pathology in autoimmune disease. IL-17A and its receptor (IL-17RA) are the founding members of a newly described family of cytokines and receptors that have unique structural features which distinguish them from other cytokine families. Research defining the signal transduction pathways induced by IL-17R family cytokines has lagged behind that of other cytokine families, but studies in the past 2 years have begun to delineate unusual functional motifs and new proximal signalling mediators used by the IL-17R family to mediate downstream events.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“most documented IL-17R signaling occurs in non-hematopoietic cells, particularly cells of epithelial and mesenchymal origin [44,45].”
From The Kallikrein-Kinin System: A Novel Mediator of IL-17-Driven Anti-Candida Immunity in the Kidney (2016) · cites this paper as [44]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A., & Coffman, R. L. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.7.2348 · Cited by 7,506
Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L., & Kuchroo, V. K. (2006) · Nature · doi:10.1038/nature04753 · Cited by 6,992
Ivanov, I. I., McKenzie, B. S., Zhou, L., Tadokoro, C. E., Lepelley, A., Lafaille, J. J., Cua, D. J., & Littman, D. R. (2006) · Cell · doi:10.1016/j.cell.2006.07.035 · Cited by 5,145
Harrington, L. E., Hatton, R. D., Mangan, P. R., Turner, H., Murphy, T. L., Murphy, K. M., & Weaver, C. T. (2005) · Nature Immunology · doi:10.1038/ni1254 · Cited by 4,742
A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17
Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y.-H., Wang, Y., Hood, L., Zhu, Z., Tian, Q., et al. (2005) · Nature Immunology · doi:10.1038/ni1261 · Cited by 4,265
IL-23 drives a pathogenic T cell population that induces autoimmune inflammation
Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A., & Cua, D. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041257 · Cited by 4,099
Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605
Transforming growth factor-β induces development of the TH17 lineage
Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087
A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene
Duerr, R. H., Taylor, K. D., Brant, S. R., Rioux, J. D., Silverberg, M. S., Daly, M. J., Steinhart, A. H., Abraham, C., Regueiro, M., Griffiths, A., et al. (2006) · Science · doi:10.1126/science.1135245 · Cited by 3,039
Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., et al. (2003) · Nature · doi:10.1038/nature01355 · Cited by 2,906
Cited by
Psoriasis Pathogenesis and Treatment
Rendon, A., & Schäkel, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061475 · Cited by 2,064
“In nail psoriasis and psoriatic arthritis (PsA), an increased expression of TNF-α, NFκB, IL-6, and IL-8 in psoriasis-affected nails is consistent with the inflammatory markers found on lesional psoriatic skin [73].”
BackgroundNF-κB, the first quarter-century: remarkable progress and outstanding questions
Hayden, M. S., & Ghosh, S. (2012) · Genes & Development · doi:10.1101/gad.183434.111 · Cited by 1,693
Innate IL-17-producing cells: the sentinels of the immune system
Cua, D. J., & Tato, C. M. (2010) · Nature Reviews Immunology · doi:10.1038/nri2800 · Cited by 1,578
“We now have a fundamental understanding of how the IL-17R signalling pathway, through the adaptor molecule ACT1 (also known as CIKS) and the transcription factor nuclear factor- κB (NF-κB), induces downstream mediators, including IL-6, CXCL8 and CC-chemokine ligand 20 (CCL20”
BackgroundTargeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414
CD4 + T Cells: Differentiation and Functions
Luckheeram, R. V., Zhou, R., Verma, A. D., & Xia, B. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/925135 · Cited by 1,381
Functional Specialization of Interleukin-17 Family Members
Iwakura, Y., Ishigame, H., Saijo, S., & Nakae, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.012 · Cited by 1,289
Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity
Puel, A., Cypowyj, S., Bustamante, J., Wright, J. F., Liu, L., Lim, H. K., Migaud, M., Israel, L., Chrabieh, M., Audry, M., et al. (2011) · Science · doi:10.1126/science.1200439 · Cited by 1,056
Pivotal Role of Dermal IL-17-Producing γδ T Cells in Skin Inflammation
Cai, Y., Shen, X., Ding, C., Qi, C., Li, K., Li, X., Jala, V. R., Zhang, H.-G., Wang, T., Zheng, J., et al. (2011) · Immunity · doi:10.1016/j.immuni.2011.08.001 · Cited by 1,026
“IL-17A and IL-17F mediate inflammatory activities via the IL-17R complex, comprised of the IL-17RA and IL-17RC subunits (Gaffen, 2009).”
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Papp, K. A., Leonardi, C., Menter, A., Ortonne, J.-P., Krueger, J. G., Kricorian, G., Aras, G., Li, J., Russell, C. B., Thompson, E. H. Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109017 · Cited by 941
“Oral or intramuscular glucocorticoids 5 (13) 4 (10) 3 (8) 4 (10) 5 (12) 16 (10)”
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Self-citationIL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785
“IL-17 signaling does not activate the non-canonical NF-κB pathway [30].”
BackgroundSelf-citationEvidence for a cross-talk between human neutrophils and Th17 cells
Pelletier, M., Maggi, L., Micheletti, A., Lazzeri, E., Tamassia, N., Costantini, C., Cosmi, L., Lunardi, C., Annunziato, F., Romagnani, S., et al. (2010) · Blood · doi:10.1182/blood-2009-04-216085 · Cited by 782
Hillmer, E. J., Zhang, H., Li, H. S., & Watowich, S. S. (2016) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.05.001 · Cited by 740
“of immune effectors such as anti-microbial peptides, chemokines and granulopoietic cytokines [208,209].”
BackgroundMeng, F., Wang, K., Aoyama, T., Grivennikov, S. I., Paik, Y., Scholten, D., Cong, M., Iwaisako, K., Liu, X., Zhang, M., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.049 · Cited by 711
Inflammation, Immunity, and Hypertensive End-Organ Damage
McMaster, W. G., Kirabo, A., Madhur, M. S., & Harrison, D. G. (2015) · Circulation Research · doi:10.1161/circresaha.116.303697 · Cited by 708
“These receptor chains are thought to heterodimerize on ligand binding and signal through the adaptor molecule Act1 and tumor necrosis receptor–associated factor-6, leading to nuclear factor kappa B, mitogen-activated protein kinase and CCAAT-enhancer–binding protein-δ activation.(35) Importantly, IL-17A seems to act s…”
BackgroundBusse, W. W., Holgate, S., Kerwin, E., Chon, Y., Feng, J., Lin, J., & Lin, S.-L. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201212-2318oc · Cited by 666
Neutrophil cell surface receptors and their intracellular signal transduction pathways
Futosi, K., Fodor, S., & Mócsai, A. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.06.034 · Cited by 642
“Further details on TGFβ-receptor signal transduction [178,179] and IL17-mediated inflammatory responses and IL-17 receptor signaling [180–184] can be found in excellent recent reviews.”
BackgroundThe IL-23/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses
Lowes, M. A., Russell, C. B., Martin, D. A., Towne, J. E., & Krueger, J. G. (2013) · Trends in Immunology · doi:10.1016/j.it.2012.11.005 · Cited by 537
Proinflammatory T helper type 17 cells are effective B-cell helpers
Mitsdoerffer, M., Lee, Y., Jäger, A., Kim, H.-J., Korn, T., Kolls, J. K., Cantor, H., Bettelli, E., & Kuchroo, V. K. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009234107 · Cited by 534
“IL-17A, IL-17F, IL-21, and IL-22.”
BackgroundInfluentialThe Role of IL-17 and related cytokines in inflammatory autoimmune diseases
Kuwabara, T., Ishikawa, F., Kondo, M., & Kakiuchi, T. (2017) · Mediators of Inflammation · doi:10.1155/2017/3908061 · Cited by 519
“Upon IL-17 stimulation, mRNA is dissociated and stabilized [29, 30].”
BackgroundTh17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions
Patel, D. D., & Kuchroo, V. K. (2015) · Immunity · doi:10.1016/j.immuni.2015.12.003 · Cited by 486
Interleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475
The IL-17 Family of Cytokines in Psoriasis: IL-17A and Beyond
Brembilla, N. C., Senra, L., & Boehncke, W.-H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01682 · Cited by 475
“Consistently, inborn errors of IL-17F, as well as of IL-17RA or ACT1, display chronic mucocutaneous candidiasis (74).”
BackgroundInfluentialBasic biology and role of interleukin‐17 in immunity and inflammation
Zenobia, C., & Hajishengallis, G. (2015) · Periodontology 2000 · doi:10.1111/prd.12083 · Cited by 470
“The figure was drawn based on information from several sources (18, 47, 131, 141).”
BackgroundMethodTRAF molecules in cell signaling and in human diseases
Xie, P. (2013) · Journal of Molecular Signaling · doi:10.1186/1750-2187-8-7 · Cited by 466
“Act1 is a U-box E3 ubiquitin ligase that contains both a SEFIR domain and TIMs, and further recruits TRAF6, TRAF2 and TRAF5 [12,152,153].”
BackgroundThe Emerging Role of IL-17 in the Pathogenesis of Psoriasis: Preclinical and Clinical Findings
Martin, D. A., Towne, J. E., Kricorian, G., Klekotka, P., Gudjonsson, J. E., Krueger, J. G., & Russell, C. B. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.194 · Cited by 466
“Much less is known about IL-17B and IL-17D, but IL-17B is believed to signal through IL-17 receptor B (Shi et al., 2000; Gaffen, 2009).”
InfluentialPerera, G. K., Di Meglio, P., & Nestle, F. O. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132448 · Cited by 462
Molecular Biology of Atherosclerosis
Hopkins, P. N. (2013) · Physiological Reviews · doi:10.1152/physrev.00004.2012 · Cited by 459
Janus kinase inhibitors in autoimmune diseases
O'Shea, J. J., Kontzias, A., Yamaoka, K., Tanaka, Y., & Laurence, A. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202576 · Cited by 453
Inflammation and oncogenesis: a vicious connection
Grivennikov, S. I., & Karin, M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.004 · Cited by 456
The IL-23-IL-17 axis in inflammatory arthritis
Lubberts, E. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.53 · Cited by 442
Immunity against Staphylococcus aureus cutaneous infections
Miller, L. S., & Cho, J. S. (2011) · Nature Reviews Immunology · doi:10.1038/nri3010 · Cited by 434
The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss
Eskan, M. A., Jotwani, R., Abe, T., Chmelar, J., Lim, J.-H., Liang, S., Ciero, P. A., Krauss, J. L., Li, F., Rauner, M., et al. (2012) · Nature Immunology · doi:10.1038/ni.2260 · Cited by 429
Preshaw, P. M., & Taylor, J. J. (2011) · Journal of Clinical Periodontology · doi:10.1111/j.1600-051x.2010.01671.x · Cited by 422
Essential Role of IL-17A in the Formation of a Mycobacterial Infection-Induced Granuloma in the Lung
Okamoto Yoshida, Y., Umemura, M., Yahagi, A., O’Brien, R. L., Ikuta, K., Kishihara, K., Hara, H., Nakae, S., Iwakura, Y., & Matsuzaki, G. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903332 · Cited by 421
“IL-17A and IL17F bind a receptor complex composed of IL-17RA and IL-17RC (44).”
BackgroundTaylor, P. R., Roy, S., Leal, S. M., Sun, Y., Howell, S. J., Cobb, B. A., Li, X., & Pearlman, E. (2014) · Nature Immunology · doi:10.1038/ni.2797 · Cited by 410
IL-17 in Chronic Inflammation: From Discovery to Targeting
Beringer, A., Noack, M., & Miossec, P. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.01.001 · Cited by 402
Li, R., Zhou, R., Wang, H., Li, W., Pan, M., Yao, X., Zhan, W., Yang, S., Xu, L., Ding, Y., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-019-0312-y · Cited by 386
“It is wellknown that the IL17 receptor (IL-17R) activates downstream NFκB via the transduction complex IL-17R-Act1TRAF6 [40].”
BackgroundEssentials of Th17 cell commitment and plasticity
Muranski, P., & Restifo, N. P. (2013) · Blood · doi:10.1182/blood-2012-09-378653 · Cited by 383
“The proinflammatory effects of IL-17 are mediated through the IL-17 receptor (IL-17R), composed of IL-17RA and IL-17RC subunits.(78) IL-17R is widely expressed by immune system cells (T and B lymphocytes and neutrophils), and by many other tissues (epithelium, endothelium, fibroblasts, mesenchymal stromal cells, and k…”
BackgroundNF-κB in inflammation and renal diseases
Zhang, H., & Sun, S.-C. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0056-4 · Cited by 383
“NF-κB not only promotes induction of Th17 cells but also serves as a major transcription factor that is actived by IL-17 and mediates the inflammatory functions of Th17 cells [53, 54].”
BackgroundBaliwag, J., Barnes, D. H., & Johnston, A. (2015) · Cytokine · doi:10.1016/j.cyto.2014.12.014 · Cited by 373
“The IL-17 family consists of six ligands (IL-17A through IL-17E) and five receptors (IL-17RA through IL-17RE), with IL-17A and IL-17F sharing the greatest homology and binding to the same IL-17RA and IL-17RC receptor complex [61].”
BackgroundPathological versus protective functions of IL-22 in airway inflammation are regulated by IL-17A
Sonnenberg, G. F., Nair, M. G., Kirn, T. J., Zaph, C., Fouser, L. A., & Artis, D. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20092054 · Cited by 380
“In contrast, 1302 IL-17 regulates IL-22 function in the lung | Sonnenberg et al. (Kotenko et al., 2001; Lejeune et al., 2002; Gaffen, 2009).”
Background“Do We Know Jack” About JAK? A Closer Look at JAK/STAT Signaling Pathway
Bousoik, E., & Montazeri Aliabadi, H. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00287 · Cited by 376
“IL-22 R Colorectal JAK1; TYK2 STAT3 (87)”
Evolutionary divergence and functions of the human interleukin (IL) gene family
Brocker, C., Thompson, D., Matsumoto, A., Nebert, D. W., & Vasiliou, V. (2010) · Human Genomics · doi:10.1186/1479-7364-5-1-30 · Cited by 368
“Not only are the proteins structurally unlike other immunomodulatory cytokines, but the corresponding IL17 receptor family contains five members, IL17RA–E, which are also structurally distinct from those used by other cytokines.(149) Perhaps not surprisingly, these receptors are coupled to signal transduction pathways…”
BackgroundGriffin, G. K., Newton, G., Tarrio, M. L., Bu, D.-X., Maganto-Garcia, E., Azcutia, V., Alcaide, P., Grabie, N., Luscinskas, F. W., Croce, K. J., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200385 · Cited by 364
“expression of the IL-17R complex, IL-17 signaling has relevance for a range of cellular targets and organ-specific immune functions (6, 7).”
BackgroundTh17 cells in immunity to Candida albicans
Hernández-Santos, N., & Gaffen, S. L. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.04.008 · Cited by 361
Self-citationInterleukin-17 and its expanding biological functions
Xu, S., & Cao, X. (2010) · Cellular & Molecular Immunology · doi:10.1038/cmi.2010.21 · Cited by 357
Guilloteau, K., Paris, I., Pedretti, N., Boniface, K., Juchaux, F., Huguier, V., Guillet, G., Bernard, F.-X., Lecron, J.-C., & Morel, F. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902464 · Cited by 353
“Interestingly, the presence of NFkB, STAT3, and MAPK signaling cytokines seems crucial for this synergy, that could be reinforced by C/EBP transcription factors activation and/or mRNA stabilization induced by IL-17A (26).”
Backgroundvan Hamburg, J. P., Asmawidjaja, P. S., Davelaar, N., Mus, A. M. C., Colin, E. M., Hazes, J. M. W., Dolhain, R. J. E. M., & Lubberts, E. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30093 · Cited by 341
“In the human system, IL-17A has a far higher affinity for IL-17RA than for IL-17RC, whereas IL-17F has a higher affinity for IL-17RC than for IL-17RA (50).”
BackgroundThe role of IL-17 in CNS diseases
Waisman, A., Hauptmann, J., & Regen, T. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1402-7 · Cited by 340
“There is an ample number of reviews summarizing this topic [16, 19–21, 34, 69, 88, 98] but for the sake of this particular review, we will briefly summarize the main points.”
BackgroundRuiz de Morales, J. M. G., Puig, L., Daudén, E., Cañete, J. D., Pablos, J. L., Martín, A. O., Juanatey, C. G., Adán, A., Montalbán, X., Borruel, N., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.102429 · Cited by 338
“Liver is one of the main producers of IL-17A [82] and IL-17RA is thoroughly expressed in liver cells as hepatocytes, sinusoidal cells, biliary cells, and stellate cells [82,83].”
BackgroundMonin, L., & Gaffen, S. L. (2018) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a028522 · Cited by 339
Self-citationHe, D., Li, H., Yusuf, N., Elmets, C. A., Li, J., Mountz, J. D., & Xu, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902574 · Cited by 334
Baldeviano, G. C., Barin, J. G., Talor, M. V., Srinivasan, S., Bedja, D., Zheng, D., Gabrielson, K., Iwakura, Y., Rose, N. R., & Cihakova, D. (2010) · Circulation Research · doi:10.1161/circresaha.109.213157 · Cited by 334
Interleukin 17A: Toward a new understanding of psoriasis pathogenesis
Lynde, C. W., Poulin, Y., Vender, R., Bourcier, M., & Khalil, S. (2014) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2013.12.036 · Cited by 335
JAK–STAT signaling pathway in the pathogenesis of atopic dermatitis: An updated review
Huang, I.-H., Chung, W.-H., Wu, P.-C., & Chen, C.-B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1068260 · Cited by 329
“The IL-17 receptor comprises IL-17RA and IL-17RC, which present different affinities to IL-17A and IL-17F, resulting in different ligand preferences depending on the ratios of IL-17RA and IL17RC in the receptor complexes (54).”
BackgroundZhou, X., Fragala, M. S., McElhaney, J. E., & Kuchel, G. A. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833cf3bc · Cited by 327
Scanning the Immunopathogenesis of Psoriasis
Chiricozzi, A., Romanelli, P., Volpe, E., Borsellino, G., & Romanelli, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19010179 · Cited by 320
“IL-17 is considered the most relevant cytokine of this class as it shows the highest biological activity and marked inflammatory effects [149].”
BackgroundSong, X., Zhu, S., Shi, P., Liu, Y., Shi, Y., Levin, S. D., & Qian, Y. (2011) · Nature Immunology · doi:10.1038/ni.2155 · Cited by 312
Role of Th17 Cells in the Pathogenesis of Human IBD
Gálvez, J. (2014) · ISRN Inflammation · doi:10.1155/2014/928461 · Cited by 319
“Both IL-17A and IL-17F have similar functions by targeting both immune and nonimmune cells, and they have been reported to play a key role in the Th17-mediated inflammatory response [33], through the IL-17 receptorA (IL-17RA)-IL-17RCheterodimer [34], showing a much higher affinity for IL-17A than for IL-17F.”
BackgroundBharadwaj, U., Kasembeli, M. M., Robinson, P., & Tweardy, D. J. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018440 · Cited by 314
“STAT3 is also essential for Th17 differentiation mediated by IL-6/transforming growth factor (TGF)-b/IL-21 (Laurence et al., 2007; Nurieva et al., 2007; Yang et al., 2007b; Zhou et al., 2007) and by IL-23/STAT3 (Ivanov et al., 2006; Yang et al., 2008b; Gaffen, 2009, 2011).”
BackgroundEffect of IL-17A blockade with secukinumab in autoimmune diseases
Patel, D. D., Lee, D. M., Kolbinger, F., & Antoni, C. (2013) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202371 · Cited by 313
“IL-17A: ROLES IN IMMUNITY AND AUTOIMMUNE DISEASE IL-17A is a dimeric glycoprotein with biological functions that bridge innate and adaptive immunity.(3) 4 In the circulation, the IL-17A cytokine exists as either a homodimer of two IL-17A chains or a heterodimer with IL-17F.”
BackgroundSelected cytokine pathways in rheumatoid arthritis
Noack, M., & Miossec, P. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0619-z · Cited by 303
“In turn, Act1, which also contains a TRAF-binding domain, recruits TRAF6 [150, 203] leading to the activation of the classical NFκB and the MAPK pathway and possibly the phosphoinositide-3 kinase (PI3K) pathway [88].”
BackgroundInterleukin-17A and Keratinocytes in Psoriasis
Furue, M., Furue, K., Tsuji, G., & Nakahara, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041275 · Cited by 300
“These cells express RORγt (RORC) as the master transcription factor [122] and promoted the anti-infectious defense in the mucosa and skin [96], whereas excessive exposure to IL-23 induces their transformation into autoimmune or autoinflammatory immune cells [123,124].”
BackgroundJAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
Fragoulis, G. E., McInnes, I. B., & Siebert, S. (2019) · Rheumatology · doi:10.1093/rheumatology/key276 · Cited by 296
Boisson, B., Wang, C., Pedergnana, V., Wu, L., Cypowyj, S., Rybojad, M., Belkadi, A., Picard, C., Abel, L., Fieschi, C., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.002 · Cited by 293
Deodhar, A., Mease, P. J., McInnes, I. B., Baraliakos, X., Reich, K., Blauvelt, A., Leonardi, C., Porter, B., Das Gupta, A., Widmer, A., et al. (2019) · Arthritis Research & Therapy · doi:10.1186/s13075-019-1882-2 · Cited by 292
“It does not directly influence the Th1 pathway and, thus, is expected to leave Th1-based host immunity largely intact, which may improve the overall safety profile [3, 4, 10].”
Recent advances in the IL-17 cytokine family
Gaffen, S. L. (2011) · Current Opinion in Immunology · doi:10.1016/j.coi.2011.07.006 · Cited by 283
“Genes induced by IL-17 encode antimicrobial proteins (AMPs; b defensins, cathelicidin, RegIII, lipocalin 2, salivary histatins), neutrophil-activating factors (G-CSF, CXC chemokines), and inducers of the acute phase response (IL-6) [4].”
InfluentialSelf-citationIL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 282
Pappu, R., Ramirez-Carrozzi, V., & Sambandam, A. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03465.x · Cited by 281
Saunte, D. M., Mrowietz, U., Puig, L., & Zachariae, C. (2017) · British Journal of Dermatology · doi:10.1111/bjd.15015 · Cited by 270
The role of antigen presenting cells in multiple sclerosis
Chastain, E. M. L., Duncan, D. S., Rodgers, J. M., & Miller, S. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.008 · Cited by 266
“Th17 cells are characterized by the production of IL-17A, IL-17F, and IL-22 [57].”
IL-17 and Th17 Cells in Atherosclerosis: Subtle and Contextual Roles
Taleb, S., Tedgui, A., & Mallat, Z. (2015) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.114.303567 · Cited by 260
McGonagle, D. G., McInnes, I. B., Kirkham, B. W., Sherlock, J., & Moots, R. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215356 · Cited by 254
Th17 Cytokines and the Gut Mucosal Barrier
Blaschitz, C., & Raffatellu, M. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9368-7 · Cited by 248
“Receptors of IL-17A and IL-17F (IL-17Ra and IL-17Rc) are expressed in several cell types, while receptors for IL-22 and IL-26 are expressed solely by epithelial cells [45–48].”
BackgroundThe role of interleukin-17 in tumor development and progression
Zhao, J., Chen, X., Herjan, T., & Li, X. (2020) · Journal of Experimental Medicine · doi:10.1084/jem.20190297 · Cited by 248
“…complex that consists of IL-17 receptor A (IL-17RA) and IL-17RC (Chang and Dong, 2007; Chen and Kolls, 2017; Ely et al., 2009; Fossiez et al., 1996; Gaffen, 2009; Gu et al., 2013; Hymowitz et al., 2001; Kuestner et al., 2007; Toy et al., 2006; Wright et al., 2008; Wright et al., 2007; Yao et al.,…”
BackgroundUpdate on psoriasis immunopathogenesis and targeted immunotherapy
Mahil, S. K., Capon, F., & Barker, J. N. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-015-0539-8 · Cited by 245
“Keratinocytes are the predominant cells that express IL-17 receptors (IL-17R; likely consisting of two IL17RA subunits complexed with one IL-17RC subunit) in psoriasis [110].”
BackgroundKirkham, B. W., Kavanaugh, A., & Reich, K. (2014) · Immunology · doi:10.1111/imm.12142 · Cited by 243
γδ T cells protect against lung fibrosis via IL-22
Simonian, P. L., Wehrmann, F., Roark, C. L., Born, W. K., O'Brien, R. L., & Fontenot, A. P. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100061 · Cited by 242
“2249 likely determines where they exert their functional capabilities (Gaffen, 2009).”
BackgroundOld and New Biological Therapies for Psoriasis
Rønholt, K., & Iversen, L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18112297 · Cited by 240
“Expression of IL-17C, but not IL-25, is increased in psoriatic lesions, which indicates a less important role for IL-25 in psoriasis [116,120].”
BackgroundTh17 Response and Inflammatory Autoimmune Diseases
Waite, J. C., & Skokos, D. (2012) · International Journal of Inflammation · doi:10.1155/2012/819467 · Cited by 238
“The IL-17 receptor family also has five members with conserved extracellular fibronectin III-like domains and cytoplasmic “similar expression to FGF/IL-17R” (SEFIR) domains [22].”
Backgroundβ-Defensin 2 is a responsive biomarker of IL-17A–driven skin pathology in patients with psoriasis
Kolbinger, F., Loesche, C., Valentin, M.-A., Jiang, X., Cheng, Y., Jarvis, P., Peters, T., Calonder, C., Bruin, G., Polus, F., et al. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.06.038 · Cited by 238
“The IL-17 family of cytokines includes 6 members (IL-17A to IL-17F) that function as homodimers or heterodimers to signal through a family of cytokine receptors with multiple chains (IL-17RA to IL-17RE), with IL-17A and IL-17F signaling through a receptor complex composed of IL-17RA and IL-17RC.(2,3) Circulating level…”
BackgroundIL-17 family member cytokines: Regulation and function in innate immunity
Reynolds, J. M., Angkasekwinai, P., & Dong, C. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2010.10.002 · Cited by 235
“expressed receptors, IL-17RA, IL-17RC, or IL-17RA/IL-17RC, respectively [1,23–26].”
The role of interleukin-17 in the pathogenesis of rheumatoid arthritis
Gaffen, S. L. (2009) · Current Rheumatology Reports · doi:10.1007/s11926-009-0052-y · Cited by 235
“These receptors belong to a specifi c subclass of cytokine receptors with distinct molecular features that distinguish this family from other types of receptors [ 19 ].”
BackgroundSelf-citationSun, D., Novotny, M., Bulek, K., Liu, C., Li, X., & Hamilton, T. (2011) · Nature Immunology · doi:10.1038/ni.2081 · Cited by 232
Gu, F.-M., Li, Q.-L., Gao, Q., Jiang, J.-H., Zhu, K., Huang, X.-Y., Pan, J.-F., Yan, J., Hu, J.-H., Wang, Z., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-150 · Cited by 227
“Given that many types of tumor cells bear IL-17 receptor alpha (IL17RA) [15,16], the specific receptor for IL-17, IL-17 may have a direct impact on the biological behavior of tumor cells in the local microenvironment.”
BackgroundResultWu, L., Chen, X., Zhao, J., Martin, B., Zepp, J. A., Ko, J. S., Gu, C., Cai, G., Ouyang, W., Sen, G., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20150204 · Cited by 221
“The receptor for IL-17 (IL-17A) is a heterodimeric complex composed of two subunits, IL-17RA and IL-17RC (Toy et al., 2006; Gaffen, 2009; Zhang et al., 2014).”
BackgroundCruz, F. F., Borg, Z. D., Goodwin, M., Sokocevic, D., Wagner, D. E., Coffey, A., Antunes, M., Robinson, K. L., Mitsialis, S. A., Kourembanas, S., et al. (2015) · Stem Cells Translational Medicine · doi:10.5966/sctm.2014-0280 · Cited by 221
Cytokine-Induced Modulation of Colorectal Cancer
Mager, L. F., Wasmer, M.-H., Rau, T. T., & Krebs, P. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00096 · Cited by 216
Liu, L., Kikly, K., Lu, J., Allan, B., Tang, Y., Tetreault, J., Chow, C.-K., Barmettler, B., Nelson, J., Bina, H., et al. (2016) · Journal of Inflammation Research · doi:10.2147/jir.s100940 · Cited by 208
The activation and regulation of IL-17 receptor mediated signaling
Song, X., & Qian, Y. (2013) · Cytokine · doi:10.1016/j.cyto.2013.03.014 · Cited by 206
Cytokines IL-17 and IL-22 in the host response to infection
Valeri, M., & Raffatellu, M. (2016) · Pathogens and Disease · doi:10.1093/femspd/ftw111 · Cited by 202
“…and activates NF-κB and MAP kinases for the induction of proinflammatory mediators such as IL-6, IL-8, granulocyte-macrophage colony-stimulating factor (GM-CSF), some chemokines (CXCL1, CXCL10, CCL2, CCL7, CCL20) and matrix metalloproteinase-3 (MMP3) and MMP13 (Fossiez et al. 1996; Gaffen 2009).”
BackgroundNorlander, A. E., Saleh, M. A., Kamat, N. V., Ko, B., Gnecco, J., Zhu, L., Dale, B. L., Iwakura, Y., Hoover, R. S., McDonough, A. A., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.116.07493 · Cited by 201
“IL-17A shares 50% sequence similarity with IL-17F, and both can bind as homo- or heterodimers to the same receptor complex composed of IL-17RA and IL-17RC subunits.(9) The role of IL-17F in hypertension is previously unknown.”
BackgroundEffects of interleukin (IL)-17A and IL-17F in human rheumatoid arthritis synoviocytes
Hot, A., & Miossec, P. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.143768 · Cited by 201
“Starting with the first IL-17 receptor (now referred to as IL-17RA), the IL-17 receptor (IL-17R) family now includes IL-17RA, IL-17RB, IL-17RC, IL-17RD and IL-17RE.”
BackgroundIL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells
Bär, E., Whitney, P. G., Moor, K., Reis e Sousa, C., & LeibundGut-Landmann, S. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.002 · Cited by 197
“IL-17RA signaling is regulated by a complex including Act1 and TNF receptor associated factor 6 (TRAF6), which induces the expression of genes encoding proinflammatory cytokines, chemokines, and antimicrobial peptides (Gaffen, 2009).”
BackgroundReprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways
Futosi, K., Fodor, S., & Mócsai, A. (2013) · International Immunopharmacology · doi:10.1016/j.intimp.2013.11.010 · Cited by 197
IL-17A in Psoriasis and Beyond: Cardiovascular and Metabolic Implications
von Stebut, E., Boehncke, W.-H., Ghoreschi, K., Gori, T., Kaya, Z., Thaci, D., & Schäffler, A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03096 · Cited by 199
“IL-17RA−/− mice were protected from inducing DCM, although they developed myocarditis comparable to WT controls (104).”
BackgroundInfluentialNew Insights in the Immunologic Basis of Psoriasis
Nograles, K. E., Davidovici, B., & Krueger, J. G. (2010) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/j.sder.2010.03.001 · Cited by 196
Structural basis of receptor sharing by interleukin 17 cytokines
Ely, L. K., Fischer, S., & Garcia, K. C. (2009) · Nature Immunology · doi:10.1038/ni.1813 · Cited by 195
Zhang, J., Wang, D., Wang, L., Wang, S., Roden, A. C., Zhao, H., Li, X., Prakash, Y. S., Matteson, E. L., Tschumperlin, D. J., et al. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00301.2018 · Cited by 194
“Consistent with other reports, our data support a mechanism of fibroblast activation by IL-17A occurring as a direct interaction with the fibroblast IL-17A/IL-17RA axis (17, 20, 31, 57).”
Result
Metadata
- Authors
- Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Gaffen, Sarah L.
- ORCID
- Gaffen, Sarah L.
- Venue
- Nature reviews. Immunology
- Published
- 2009-07-03
- Volume
- 9
- Issue
- 8
- Pages
- 556-567
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC2821718
- OpenAlex
- W2020233428
- Cited by
- 1,475
- References
- 111
- Citations by year
- 2026: 66 · 2025: 87 · 2024: 57 · 2023: 76 · 2022: 80 · 2021: 118 · 2020: 76 · 2019: 96 · 2018: 81 · 2017: 92 · 2016: 108 · 2015: 91 · 2014: 107 · 2013: 89 · 2012: 90
- FWCI
- 7.31
- Type
- journal article
- Language
- en
- Update notices
- erratum (2009-08-07)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR054389)
- National Institute of Dental and Craniofacial Research (R21DE018822)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- IL-17A, IL-17RA, Th17 cells, cytokine signaling, signal transduction, innate and adaptive immunity, autoimmune disease, inflammatory pathology
- MeSH terms
- Animals, Autoimmune Diseases, T-Lymphocytes, Helper-Inducer, Humans, Inflammation, Signal Transduction, Cytokines, Interleukin-17, Receptors, Interleukin-17
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.